Search Results

There are 1839 results for: content related to: Double-blind, randomized non-inferiority trial of a novel botulinum toxin A processed from the strain CBFC 26, compared with onabotulinumtoxin A in the treatment of glabellar lines

  1. You have free access to this content
    OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program

    Headache: The Journal of Head and Face Pain

    Volume 50, Issue 6, June 2010, Pages: 921–936, David W. Dodick, Catherine C. Turkel, Ronald E. DeGryse, Sheena K. Aurora, Stephen D. Silberstein, Richard B. Lipton, Hans-Christoph Diener and Mitchell F. Brin

    Article first published online : 7 MAY 2010, DOI: 10.1111/j.1526-4610.2010.01678.x

  2. You have free access to this content
    Botulinum toxin type A for the treatment of lower urinary tract disorders

    International Journal of Urology

    Volume 19, Issue 3, March 2012, Pages: 202–215, Teruhiko Yokoyama, Michael B Chancellor, Keiji Oguma, Yumiko Yamamoto, Tomonori Suzuki, Hiromi Kumon and Atsushi Nagai

    Article first published online : 6 JAN 2012, DOI: 10.1111/j.1442-2042.2011.02946.x

  3. Dose response with onabotulinumtoxinA for post-stroke spasticity: A pooled data analysis

    Movement Disorders

    Volume 26, Issue 2, 1 February 2011, Pages: 209–215, Stuart A. Yablon, Mitchell F. Brin, Amanda M. VanDenburgh, Jihao Zhou, Susan M. Garabedian-Ruffalo, Susan Abu-Shakra and Frederick C. Beddingfield III

    Article first published online : 19 OCT 2010, DOI: 10.1002/mds.23426

  4. You have full text access to this OnlineOpen article
    Development of onabotulinumtoxinA for chronic migraine

    Annals of the New York Academy of Sciences

    Volume 1329, Issue 1, November 2014, Pages: 67–80, Scott M. Whitcup, Catherine C. Turkel, Ronald E. DeGryse and Mitchell F. Brin

    Article first published online : 18 AUG 2014, DOI: 10.1111/nyas.12488

  5. OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Analyses of the 56-Week PREEMPT Clinical Program

    Headache: The Journal of Head and Face Pain

    Volume 51, Issue 9, October 2011, Pages: 1358–1373, Sheena K. Aurora, Paul Winner, Marshall C. Freeman, Egilius L. Spierings, Jessica O. Heiring, Ronald E. DeGryse, Amanda M. VanDenburgh, Marissa E. Nolan and Catherine C. Turkel

    Article first published online : 29 AUG 2011, DOI: 10.1111/j.1526-4610.2011.01990.x

  6. Insights Into the Mechanism of OnabotulinumtoxinA in Chronic Migraine

    Headache: The Journal of Head and Face Pain

    Volume 51, Issue 10, November/December 2011, Pages: 1573–1577, Paul L. Durham and Roger Cady

    Article first published online : 14 NOV 2011, DOI: 10.1111/j.1526-4610.2011.02022.x

  7. You have free access to this content
    A Double-Blind Comparison of OnabotulinumtoxinA (BOTOX®) and Topiramate (TOPAMAX®) for the Prophylactic Treatment of Chronic Migraine: A Pilot Study

    Headache: The Journal of Head and Face Pain

    Volume 49, Issue 10, November/December 2009, Pages: 1466–1478, Ninan T. Mathew and Sayyed Farhan A. Jaffri

    Article first published online : 3 NOV 2009, DOI: 10.1111/j.1526-4610.2009.01566.x

  8. Difficult Urination Does Not Affect the Successful Outcome after 100U OnabotulinumtoxinA Intravesical Injection in Patients with Idiopathic Detrusor Overactivity

    LUTS: Lower Urinary Tract Symptoms

    Volume 4, Issue 1, January 2012, Pages: 29–34, Yih-Chou CHEN and Hann-Chorng KUO

    Article first published online : 12 SEP 2011, DOI: 10.1111/j.1757-5672.2011.00102.x

  9. You have full text access to this OnlineOpen article
    Patient-reported goal achievement following onabotulinumtoxinA treatment in patients with neurogenic detrusor overactivity

    Neurourology and Urodynamics

    Emmanuel Chartier-Kastler, Eric Rovner, Zsolt Hepp, Kristin Khalaf, Quanhong Ni and Michael Chancellor

    Article first published online : 6 APR 2015, DOI: 10.1002/nau.22757

  10. You have full text access to this OnlineOpen article
    Real-World Economic Impact of OnabotulinumtoxinA in Patients With Chronic Migraine

    Headache: The Journal of Head and Face Pain

    Volume 54, Issue 10, November/December 2014, Pages: 1565–1573, John F. Rothrock, Lisa M. Bloudek, Timothy T. Houle, Diane Andress-Rothrock and Sepideh F. Varon

    Article first published online : 8 OCT 2014, DOI: 10.1111/head.12456

  11. An Exploratory Study of Salivary Calcitonin Gene-Related Peptide Levels Relative to Acute Interventions and Preventative Treatment With OnabotulinumtoxinA in Chronic Migraine

    Headache: The Journal of Head and Face Pain

    Volume 54, Issue 2, February 2014, Pages: 269–277, Roger Cady, Ira Turner, Kent Dexter, M. E. Beach, Ryan Cady and Paul Durham

    Article first published online : 22 OCT 2013, DOI: 10.1111/head.12250

  12. You have full text access to this OnlineOpen article
    OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program

    Acta Neurologica Scandinavica

    Volume 129, Issue 1, January 2014, Pages: 61–70, S. K. Aurora, D. W. Dodick, H.-C. Diener, R. E. DeGryse, C. C. Turkel, R. B. Lipton and S. D. Silberstein

    Article first published online : 20 SEP 2013, DOI: 10.1111/ane.12171

  13. Chapter 5: Clinical data in neurogenic detrusor overactivity (NDO) and overactive bladder (OAB)

    Neurourology and Urodynamics

    Volume 33, Issue S3, July 2014, Pages: S26–S31, Francisco Cruz and Victor Nitti

    Article first published online : 8 JUL 2014, DOI: 10.1002/nau.22630

  14. You have free access to this content
    Method of Injection of OnabotulinumtoxinA for Chronic Migraine: A Safe, Well-Tolerated, and Effective Treatment Paradigm Based on the PREEMPT Clinical Program

    Headache: The Journal of Head and Face Pain

    Volume 50, Issue 9, October 2010, Pages: 1406–1418, Andrew Blumenfeld, Stephen D. Silberstein, David W. Dodick, Sheena K. Aurora, Catherine C. Turkel and William J. Binder

    Article first published online : 4 OCT 2010, DOI: 10.1111/j.1526-4610.2010.01766.x

  15. Scientific Programme 44th Annual Meeting of the International Continence Society (ICS) 20—24 October 2014, Rio de Janeiro, Brazil

    Neurourology and Urodynamics

    Volume 33, Issue 6, August 2014, Pages: 631–1071,

    Article first published online : 7 JUL 2014, DOI: 10.1002/nau.22655

  16. You have full text access to this OnlineOpen article
    OnabotulinumtoxinA improves urodynamic outcomes in patients with neurogenic detrusor overactivity

    Neurourology and Urodynamics

    Volume 32, Issue 8, November 2013, Pages: 1109–1115, Eric Rovner, Roger Dmochowski, Christopher Chapple, Catherine Thompson, Wayne Lam and Cornelia Haag-Molkenteller

    Article first published online : 6 FEB 2013, DOI: 10.1002/nau.22376

  17. You have full text access to this OnlineOpen article
    Pooled analysis of the safety and tolerability of onabotulinumtoxinA in the treatment of chronic migraine

    European Journal of Neurology

    Volume 21, Issue 6, June 2014, Pages: 851–859, H.-C. Diener, D. W. Dodick, C. C. Turkel, G. Demos, R. E. DeGryse, N. L. Earl and M. F. Brin

    Article first published online : 15 MAR 2014, DOI: 10.1111/ene.12393

  18. You have full text access to this OnlineOpen article
    OnabotulinumtoxinA 100U provides significant improvements in overactive bladder symptoms in patients with urinary incontinence regardless of the number of anticholinergic therapies used or reason for inadequate management of overactive bladder

    International Journal of Clinical Practice

    Volume 68, Issue 10, October 2014, Pages: 1246–1256, K.-D. Sievert, C. Chapple, S. Herschorn, M. Joshi, J. Zhou, C. Nardo and V. W. Nitti

    Article first published online : 22 APR 2014, DOI: 10.1111/ijcp.12443

  19. Treatment satisfaction and improvement in health-related quality of life with onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity

    Neurourology and Urodynamics

    Volume 32, Issue 3, March 2013, Pages: 242–249, David Sussman, Vaishali Patel, Giulio Del Popolo, Wayne Lam, Denise Globe and Peter Pommerville

    Article first published online : 10 SEP 2012, DOI: 10.1002/nau.22293

  20. Multicenter, Randomized, Parallel-Group Study of the Safety and Effectiveness of OnabotulinumtoxinA and Hyaluronic Acid Dermal Fillers (24-mg/mL Smooth, Cohesive Gel) Alone and in Combination for Lower Facial Rejuvenation

    Dermatologic Surgery

    Volume 36, Issue s4, December 2010, Pages: 2121–2134, ALASTAIR CARRUTHERS, JEAN CARRUTHERS, GARY D. MONHEIT, PAULA G. DAVIS and GREG TARDIE

    Article first published online : 6 DEC 2010, DOI: 10.1111/j.1524-4725.2010.01705.x